Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease

By sjmartinez • February 1, 2025

Yan A, Madigan L, Korman A, Shearer S, Dulmage B, Patel T, Milani-Nejad N, Chung C, Fisher K, Kaffenberger B. Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease. Am J Clin Dermatol. 2025 Jan 31. doi: 10.1007/s40257-025-00924-0. Epub ahead of print. PMID: 39888589.

Tags: Dermatology, Publications

Cutaneous Larva Migrans

Truong A, Martin S. Cutaneous Larva Migrans. N Engl J Med. 2025 Feb 20;392(8):e22. doi: 10.1056/NEJMicm2414639. PMID: 39970399.

Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study

McLaren J, Chon Y, Gorski KS, Bernstein JA, Corren J, Hayama K, Jain V, Lima H, Sofen H, Ponnarambil S, Molfino NA, Maurer M. Tezepelumab[...]

Genetic and anatomical determinants of olfaction in dogs and wild canids

Mouton A, Bird D, Li G, Craven BA, Levine JM, Morselli M, Pellegrini M, Van Valkenburgh B, Wayne RK, Murphy WJ. Genetic and anatomical determinants[...]